When a patient survives an ischemic stroke or a transient ischemic attack, one of the most important questions becomes deceptively simple: will the antiplatelet drug clopidogrel actually work in this particular person? A new prospective study from Ziv Medical Center
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.